Literature DB >> 14933886

[New method of dosage of anaphylactic antibodies and its relation to the nitrogen of the antibody].

Z OVARY, M BRIOT.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1951        PMID: 14933886

Source DB:  PubMed          Journal:  Ann Inst Pasteur (Paris)        ISSN: 0020-2444


× No keyword cloud information.
  8 in total

1.  PASSIVE CUTANEOUS ANAPHYLAXIS IN THE GUINEA-PIG WITH RABBIT ANTIBODIES AGAINST SYNTHETIC POLYPEPTIDES.

Authors:  S BEN-EFRAIM; S FUCHS; M SELA
Journal:  Immunology       Date:  1964-03       Impact factor: 7.397

Review 2.  Human reagins: appraisal of the properties of the antibody of immediate-type hypersensitivity.

Authors:  J A Flick
Journal:  Bacteriol Rev       Date:  1972-09

3.  An isotope tracer method for passive cutaneous anaphylaxis.

Authors:  W P Faulk; H Snippe; K W Pondman
Journal:  Immunology       Date:  1971-09       Impact factor: 7.397

4.  Properties of guinea pig 7S antibodies. II. Identification of antibodies involved in passive cutaneous and systemic anaphylaxis.

Authors:  Z OVARY; B BENACERRAF; K J BLOCH
Journal:  J Exp Med       Date:  1963-06-01       Impact factor: 14.307

5.  The delayed hypersensitivity induced by antigen-antibody complexes.

Authors:  S RAFFEL; J M NEWEL
Journal:  J Exp Med       Date:  1958-12-01       Impact factor: 14.307

6.  A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system.

Authors:  B BENACERRAF; M M SEBESTYEN; S SCHLOSSMAN
Journal:  J Exp Med       Date:  1959-07-01       Impact factor: 14.307

7.  Studies on hypersensitivity. IV. The relationship between contact and delayed sensitivity: a study of the specificity of cellular immune reactions.

Authors:  P G GELL; B BENACERRAF
Journal:  J Exp Med       Date:  1961-03-01       Impact factor: 14.307

8.  THE ROLE OF COMPLEMENT IN THE PASSIVE CUTANEOUS REACTION OF MICE.

Authors:  S BEN-EFRAIM; B CINADER
Journal:  J Exp Med       Date:  1964-11-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.